Pilot results of therapy of adult Ph-negative acute lymphoblastic leukemia according to the protocol of research group of Russian hematological centers all-2009

Terapevticheskii Arkhiv

Volumn 83, Issue 7, 2011, Pages 11-17

  Parovichnikova, E N ^a   Klyasova, G A ^a   Isaev, V G ^a   Sokolov, A N ^a   Kokhno, A V ^a   Troitskaya, V V ^a   Mavrina, E V ^a   Khodunova, E E ^a   Ustinova, E N ^a   Gribanova, E O ^a   Kravchenko, S K ^a   Ryzhko, V V ^a   Kaporskaya, T S ^b   Baranova, O Yu ^c   Bondarenko, S N ^d   Nizametdinova, A S ^e   Kondakova, E V ^b   Ryltsova, T V ^f   Aluferieva, A N ^g   Samoilova, O S ^b   Skamorina, O P ^h   Gavrilova, L V ⁱ   Pristupa, A S ^j   Vopilina, N A ^k   Konstantinova, T S ^l   Kryuchkova, I V ^m   Anchukova, L V ^b   Tikunova, T S ⁿ   Kaplanov, K D ^o   Lapin, V A ^p   Tumakov, V A ^q   Kozmina, M N ^b   Chernysh, S A ^r   Podoltseva, E I ^s   Kulikov, S M ^a   Davidyan, Yu R ^a   Savchenko, V G ^a   more..

^a NATIONAL RESEARCH CENTER FOR HEMATOLOGY   (Russian Federation)

^b Regional Hospital   (Russian Federation)

^c N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^d PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

^e City Hospital N 17   (Russian Federation)

^f Regional Hospital   (Russian Federation)

^g Regional Hospital   (Russian Federation)

^h Central Hospital of GSS   (Russian Federation)

ⁱ Regional Hospital   (Russian Federation)

^j Central Regional Hospital   (Russian Federation)

^k Regional Clinical Hospital   (Russian Federation)

^l Regional Children's Hospital   (Russian Federation)

^m Research Clinical Institute   (Russian Federation)

ⁿ Regional Clinical Hospital   (Russian Federation)

^o Regional Hospital   (Russian Federation)

^p Regional Oncological Hospital   (Russian Federation)

^q Regional Pediatric Clinical Hospital   (Russian Federation)

^r SP Botkin Moscow City Clinical Hospital   (Russian Federation)

^s City Hospital N 23   (Russian Federation)

more..

Author keywords

Adult Ph negative acute lymphoblastic leukemia; L asparaginasa; Sensitivity to prednisolone

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PHILADELPHIA 1 CHROMOSOME; PILOT STUDY; RECURRENT DISEASE; REMISSION;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PHILADELPHIA CHROMOSOME; PILOT PROJECTS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; REMISSION INDUCTION; YOUNG ADULT;

EID: 80052095126     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (5)

1. Daves M. H., Hunger S., Linda S. B. et al. Longer time to the start of continuation therapy is associated with improved survival in high risk pediatric acute lumphoblastic leukemia (ALL): a report from the Children's Oncology Group (COG). Blood 2010;116(21):1322, abstr. 3223.
2. Stive J. I., Buck G., Fielding A. et al. Inability to tolerate standard therapy is a major reason for poor outcome in older adults with acute lymphoblastic leukemia (ALL): results from international MRC/ECOG trial. Blood 2010;116(21):218-219, abstr. 493.
3. Goekbuget N., Baumann A., Beck J. et al. PEG-Asparaginase intensification in adult acute lymphoblastic leukemia (ALL): significant improvement of outcome with moderate increase of liver toxicity in the German multicenter study group for adult ALL (GMALL) study 07/2003. Blood 2010;116(21):219-220, abstr. 494.
4. Rytting M. E., Kantarjian H., Thomas D. A. et al. Adolescent and young adult patients treated with modified augmented Berlin-Frankfurt-Muenster therapy. Blood 2010;116(21):1333, abstr. 3250.
5. Bassan R., Intermesoli T., Mascuilli A. et al. Pediatric type therapy including lineage-targeted methotrexate to improve eraly minimal residual disease response and survival in adult acute lymphoblastic leukemia (ALL): interim analysis of Northern Italy leukemia group study 10/07. Blood 2010;116(21):881-882, abstr. 2131.